|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Sales and other revenues (Note 4) | ||||
| Operating costs and expenses: | ||||
| Cost of products sold (exclusive of lower of cost or market inventory valuation adjustment) | ||||
| Cost of sales: | ||||
| Cost of materials and other | ||||
| Lower of cost or market inventory valuation adjustments | ||||
| Operating expenses | ||||
| Total cost of sales | ||||
| Selling, general and administrative expenses | ||||
| Depreciation and amortization | ||||
| Asset impairments | ||||
| Other operating expenses, net | ||||
| Total operating costs and expenses | ||||
| Income from operations | ||||
| Other income (expense): | ||||
| Earnings of equity method investments | ||||
| Interest income | ||||
| Gain on business interruption insurance settlement | ||||
| Gain on tariff settlement | ||||
| Gain on early extinguishment of debt | ||||
| Gain (loss) on foreign currency transactions | ||||
| Gain on sale of assets and other | ||||
| Interest expense | ||||
| Other income (expense), net (Note 5) | ||||
| Total other income (expense) | ||||
| Income before income taxes | ||||
| Income tax expense (benefit) (Note 15): | ||||
| Current | ||||
| Deferred | ||||
| Total income tax expense | ||||
| Net income | ||||
| Less: net income attributable to noncontrolling interest | ||||
| Net income attributable to HF Sinclair stockholders | ||||
| Earnings per share attributable to HF Sinclair stockholders: | ||||
| Basic (in USD per share) | ||||
| Diluted (in USD per share) | ||||
| Average number of common shares outstanding (in thousands): | ||||
| Basic (in shares) | ||||
| Diluted (in shares) | ||||
Loading...